- Home
- ZBRA vs ILMN Comparison
ZBRA vs ILMN Comparison
Compare ZBRA & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBRA
- ILMN
- Stock Information
- Founded
- ZBRA 1969
- ILMN 1998
- Country
- ZBRA United States
- ILMN United States
- Employees
- ZBRA N/A
- ILMN N/A
- Industry
- ZBRA Industrial Machinery/Components
- ILMN Medical Specialities
- Sector
- ZBRA Industrials
- ILMN Health Care
- Exchange
- ZBRA Nasdaq
- ILMN Nasdaq
- Market Cap
- ZBRA 14.7B
- ILMN 15.3B
- IPO Year
- ZBRA 1991
- ILMN 2000
- Fundamental
- Price
- ZBRA $254.26
- ILMN $120.19
- Analyst Decision
- ZBRA Buy
- ILMN Hold
- Analyst Count
- ZBRA 8
- ILMN 15
- Target Price
- ZBRA $356.13
- ILMN $114.93
- AVG Volume (30 Days)
- ZBRA 789.5K
- ILMN 2.0M
- Earning Date
- ZBRA 10-28-2025
- ILMN 10-30-2025
- Dividend Yield
- ZBRA N/A
- ILMN N/A
- EPS Growth
- ZBRA 34.78
- ILMN N/A
- EPS
- ZBRA 9.93
- ILMN 4.46
- Revenue
- ZBRA $5,255,000,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- ZBRA $10.10
- ILMN N/A
- Revenue Next Year
- ZBRA $9.79
- ILMN $2.22
- P/E Ratio
- ZBRA $26.02
- ILMN $27.15
- Revenue Growth
- ZBRA 12.87
- ILMN N/A
- 52 Week Low
- ZBRA $205.73
- ILMN $68.70
- 52 Week High
- ZBRA $427.76
- ILMN $156.51
- Technical
- Relative Strength Index (RSI)
- ZBRA 33.59
- ILMN 65.75
- Support Level
- ZBRA $260.45
- ILMN $118.50
- Resistance Level
- ZBRA $268.75
- ILMN $126.00
- Average True Range (ATR)
- ZBRA 10.29
- ILMN 5.01
- MACD
- ZBRA -3.19
- ILMN 2.42
- Stochastic Oscillator
- ZBRA 3.08
- ILMN 81.84
About ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.